gastrointestinal disease, esophageal cancer and inflammatory disease.
Conditions
Interventions
Intervention type:
Name of intervention:
Dose form / Japanese Medical Device Nomenclature:
Route of administration / Site of application:
Dose per administration:
Dosing frequency / Frequency of use:
Sponsors
Tomohiro Tada
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: patient who areee with usage of endscopic images for this study
Exclusion criteria
Exclusion criteria: patient who does not areee with usage of endscopic images for this study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| -Detection rate and detection speed of stomach cancer and esophageal cancer - Percentage of correct diagnosis in distinguishing benign or malignant tumor -Correct diagnosis rate in differentiation of inflammatory bowel disease | — |
Secondary
| Measure | Time frame |
|---|---|
| -Differentiation of presence or absence of Helicobacter pylori infection from gastritis images -Ability to pick up lesions with high cancer risk -Diagnostic ability for ulcerative colitis -Diagnosis of cancer depth -Examination of the possibility of secondary image interpretation support in gastric cancer screening -Examination of gastrointestinal lesions using magnifying and ultra-magnifying endoscopes -Examination of whether it is possible to diagnose small intestine and large intestine lesions using a capsule endoscope | — |
Countries
Japan
Contacts
Public ContactTomohiro Tada
Tada Tomohiro institute of gastroenterology and proctology
Outcome results
None listed